The International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) is the only international worldwide organization devoted to these chronic and sometimes disabling diseases involving different parts of the gastrointestinal tract. The mission of the IOIBD is to promote the health of people with IBD worldwide by setting the direction for patient care, education and research. This is in particular the case for those countries where the diseases are just evolving. Task forces of IOIBD promote scientific developments by designing non commercial clinical studies. Grants are provided for innovative start-up projects and large scale trials not receiving funds otherwise due to lack of economic or political interest. Travel grants are given to young scientists from countries with evolving IBD. The organization furthermore aims at developing clear definitions of the different manifestations of IBD as well as for the targets and endpoints of treatment in practice and research, in particular in clinical trials.
The long-term goal of IOIBD is to contribute to the elucidation of the cause of these still relatively new diseases and finally to the development of a causal and curative treatment, thereby making its existence unnecessary.
To promote the health of people with IBD worldwide by setting the direction for patient care, education and research.
Bordeaux Meeting has been postponed to Fall 2020 – 19-22 November 2020 IOIBD AGM
What are the current recommendations for IBD patients related to COVID19?
Please look at our updated guidance (update 26 March 2020) in our chapter:
latest news on left upper side of this page!